Kansas EyeCon PDF
Preview Kansas EyeCon
April 8 & 9, 2016 The Venue th 4800 W 135 St., Ste. 108 Leawood, KS 66209 Sponsored by the University of Kansas Department of Ophthalmology and the Lemoine Alumni Society Kansas EyeCon 2016 DEPARTMENT OF OPHTHALMOLOGY SCHOOL OF MEDICINE CLINICAL FACULTY 7400 State Line Rd 3901 Rainbow Blvd., Ste. 1011 Miller Prairie Village, KS 66208 Kansas City, KS 66160 Appointments: 913-588-6600 Appointments: 913-588-6688 kumed.com/kueye C. Scott Atkinson, MD Miranda Bishara, MD Dirck DeKeyser, OD William Godfrey, MD Pediatric Ophthalmology Cornea/Refractive/Cataracts Optometrist Uveitis Shree Kurup, MD Paul Munden, MD Ajay Singh, MD Jason Sokol, MD Retina and Vitreous Glaucoma & Anterior Segment Retina and Vitreous Oculofacial Plastic & Orbital Surg. John Sutphin, MD, Chair Matthew Twardowski, O.D. W. Abraham White, MD Thomas J. Whittaker, JD, MD Cornea & Anterior Segment Optometrist Comprehensive Neuro-Ophthalmology DEPARTMENT OF OPHTHALMOLOGY SCHOOL OF MEDICINE RESIDENTS 2015 – 2016 Third-Year Residents Anna Berry, MD Michelle Boyce, MD Lillian Yang, MD Pager: 0369 Pager: 0418 Pager: 1488 Second-Year Residents Derek Horkey, MD Anjulie Quick, MD Robert Null, MD Pager: 4935 Pager: 0404 Pager: 0732 First-Year Residents Luke Dolezal, MD Joshua Jones, MD Reid Mollman, MD Pager: 2016 Pager: 1487 Pager: 0447 EDUCATING TOMORROW’S GENERATION ~ CARING FOR TODAY’S Kansas EyeCon 2016 We wish to acknowledge and sincerely thank these organizations for exhibiting at this conference: Platinum Sponsors: Alcon Laboratories, Inc. Ellex Enhanced Medical Services Heidelberg Engineering Regeneron Pharmaceuticals, Inc. Shire Medical Affairs Silver Sponsors: Allergan, Inc. Bio‐Tissue Carl Zeiss Meditec, Inc. Bronze Sponsor: KU Audio‐Reader Network Kansas EyeCon 2016 The Venue th 4800 W 135 St., Ste. 108 Overland Park, KS April 8 & 9, 2016 Program Overview ‐ This conference is intended to provide ophthalmologists with an educational forum to learn about new developments in the profession and their application to patient care. Covering a cross‐section of all sub‐specialties, physicians can expect to walk away having heard evidence‐based presentations. Target Audience ‐ This program is designed to meet the needs of practicing ophthalmologists. Learning Objectives ‐ Upon completion of the educational activity, participants should be able to: Orbital Session 1. Provide an overview of the indications, history, symptoms, biopsy results and outcomes of patients with suspected giant cell arteritis; 2. Evaluate the efficacy and utility of temporal artery biopsies performed at the University of Kansas Hospital; 3. Describe the clinical presentation of orbital myeloid sarcoma; 4. Describe the natural history of the disease, as well as the available treatments; 5. Recognize the most common periorbital skin malignancy associated with immunosuppressive therapy; 6. Determine if periorbital skin malignancies while on immunosuppressive therapy result in a higher incidence of exenteration; 7. Outline the most common reasons for eye destructive procedures in a tertiary care center; 8. Recognize the most common neoplasms requiring eye destructive procedures; 9. List two major potential benefits of virtual reality technology in vision science; 10. Explain the outcomes of some virtual reality‐based interventions to improve visual scanning capabilities of patients with low vision. Cataract and Pediatric Session 11. Understand the role of microtropia in the spectrum of diplopia, strabismus and peripheral fusion; 12. Diagnose microtropia using the Bruckner red reflex test, Bagolini lens test, base out prism test and stereo testing; 13. Recognize Cataract surgery difficulties and solve these problems, or at least better manage them when they occur; 14. Identify several ways the ophthalmologist will learn over time to improve the quality of eye care for the patients served by embracing personal education through reading, personal observation and experience; 15. Learn new insights to enhance surgical outcome with cataract surgery. Anterior Segment and Refractive Session 16. List two advantages to the use of femtosecond laser for use in posterior polar cataract extraction; 17. Implement essential surgical steps to reduce complications in removal of posterior polar cataract; 18. Describe the three stages of the Dysfunctional Lens Syndrome; 19. List the advantages of Refractive Lens Exchange surgery; 20. Understand the timing and approaches to surgery in complex uveitis; 21. Diagnose uveitis patients who benefit with vitreoretinal surgery; 22. Describe risk factors for intraocular pressure elevation after dexamethasone intravitreal injection; 23. Discuss treatment interventions for increased intraocular pressure after dexamethasone intravitreal injection; 24. Provide a differential diagnosis for posterior uveitis; 25. Describe the pros and cons of treatment options for chronic posterior uveitis; 26. Describe what functional visual changes occur in diabetic retinopathy prior to development of visible vascular lesions; 27. State which cell types in the retina are involved in early diabetic retinopathy; 28. Discuss the effects of diabetes on the ocular surface and patient reported dry eye symptoms; 29. Discuss the correlation in diabetic patients of ocular surface disease, severity of diabetic retinopathy and a history of retinal laser treatment; 30. Analyze results of clinical trials in diabetic macular edema and apply them to clinical practice; 31. Manage patients with anti‐VEGF and steroid‐based therapies through the preferred dosing practices; 32. Recognize the protective effect of fenofibrate on progression of diabetic retinopathy; 33. Describe what driving forces generate the excess of vascular endothelial growth factor in advanced stages of diabetic retinopathy; 34. Summarize the interpretation of visual fields obtained by static perimetry and describe how static automated perimetry can be used over time to monitor for glaucomatous changes in a clinical setting; 35. Describe the artifacts introduced with simulated afferent pupillary defects during automated perimetry field testing; 36. Generate and interpret Humphrey Field Analyzer GPA reports; 37. Use the event and trend analysis GPA functions to determine the likelihood of progressive visual field loss in glaucoma patients. Method of Participation Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an activity evaluation/claimed credit form that should be turned it at the end of the meeting. If you have questions about this CME activity, please contact AKH Inc. at CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare Physicians This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and the University of Kansas, Department of Ophthalmology and The Lemoine Alumni Society. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians. AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. FACULTY DISCLOSURES Name Relationship Commercial Interest Abiodun E. Akinwuntan, PhD, MPH, MBA N/A Nothing to Disclose Michelle Boyce, MD N/A Nothing to Disclose Gerhard Cibis, MD N/A Nothing to Disclose Luke Dolezal, MD N/A Nothing to Disclose Luther Fry, MD N/A Nothing to Disclose Derek Horkey, MD N/A Nothing to Disclose John Hunkeler, MD N/A Nothing to Disclose Joshua Jones, MD N/A Nothing to Disclose Shree Kurup, MD N/A Nothing to Disclose Reid Mollman, MD N/A Nothing to Disclose Paul Munden, MD N/A Nothing to Disclose Robert Null, MD N/A Nothing to Disclose Anjulie Quick, MD N/A Nothing to Disclose Rithwick Rajagopal, MD N/A Nothing to Disclose Chetan Soni, MD N/A Nothing to Disclose Jason Stahl, MD N/A Nothing to Disclose Natalia Villate, MD N/A Nothing to Disclose Lillian Yang, MD N/A Nothing to Disclose PLANNER DISCLOSURES KUMC/KSEPS Staff and Planners N/A Nothing to Disclose AKH Staff and Planners N/A Nothing to Disclose Commercial Support There is no commercial support for this activity. Disclosures It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non‐commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. Disclosure of Unlabeled Use and Investigational Product This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content. LEMOINE DISTINGUISHED ALUMNI LECTURERS LECTURER TITLE DATE Timothy W. Olsen, MD Rock Chalk Retina Talk: 100 year KU 5/9/2014 KU SOM MD ‘89 Luther L. Fry, MD Standard Cataract Surgery: Tips & Tricks 5/8/2015 KU SOM MD ‘67 Learned after 40,000+ Cases John D. Hunkeler, MD Continuous Education 4/8/2016 KU SOM MD ‘67 KU Eye Residency ‘73 Alumni Speakers Luther L. Fry, MD MD: 1967 John D. Hunkeler, MD MD: 1967; Residency: 1973 Natalia Villate, MD Residency: 2008
The list of books you might like
